Among genes showing high positivity in both intra- and peri-tumour TILs, CD53 appears to be a good candidate as prognostic marker for cancer patients, since it plays a key role in anti-tumour immunity, as already reported for other members of the tetraspanin superfamily [96]. Here, CD53 is linked to neoplasm.